Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.
This report contains market size and forecasts of Artemisinin API in global, including the following market information:
Global Artemisinin API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Artemisinin API Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Artemisinin API companies in 2021 (%)
The global Artemisinin API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Extraction from Artemisia annua Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Artemisinin API include Sanofi, KPC Pharmaceuticals, Kerui nanhai, Guangxi xiancaotang, Guilin Pharmaceutical, Natural Bio-engineering, BIONEXX, CAT KHANH and BEEPZ and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Artemisinin API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artemisinin API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Artemisinin API Market Segment Percentages, by Type, 2021 (%)
Extraction from Artemisia annua
Semisynthetic Artemisinin
Global Artemisinin API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Artemisinin API Market Segment Percentages, by Application, 2021 (%)
Antimalarial Injections
Antimalarial Tablets
Global Artemisinin API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Artemisinin API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artemisinin API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Artemisinin API revenues share in global market, 2021 (%)
Key companies Artemisinin API sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies Artemisinin API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
KPC Pharmaceuticals
Kerui nanhai
Guangxi xiancaotang
Guilin Pharmaceutical
Natural Bio-engineering
BIONEXX
CAT KHANH
BEEPZ
Novanat Bioresource